CLINICAL_TRIALS
trial_result
· 2009-11-25
Clinical Trial Update: MK0524A Bioequivalence Study (0524A-059) [Phase 1]
Summary
Phase 1 bioequivalence study of MK0524A (0524A-059) in dyslipidemia has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED | Results posted: 2009-11-25